123278-03-5

Basic information

• Product Name: BUTTPARK 100\07-45
• Synonyms: BUTTPARK 100\07-45;3-CHLORO-2-IODO-BENZOIC ACID;Benzoic acid, 3-chloro-2-iodo-
• CAS NO: 123278-03-5
• Molecular Formula: C₇H₄ClIO₂
• Molecular Weight: 282.46
• Mol File: 123278-03-5.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 360.5 °C at 760 mmHg
• Flash Point: 171.8 °C
• Appearance: /
• Density: 2.077 g/cm³
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: BUTTPARK 100\07-45(CAS DataBase Reference)
• NIST Chemistry Reference: BUTTPARK 100\07-45(123278-03-5)
• EPA Substance Registry System: BUTTPARK 100\07-45(123278-03-5)

Safety Data

• Hazardous Substances Data: 123278-03-5(Hazardous Substances Data)

Usage

General Description

BUTTPARK 100\07-45 is a chemical mixture used as a corrosion inhibitor in the oil and gas industry. It is composed of a blend of organic and inorganic compounds, designed to provide protection to metal surfaces in contact with brines and drilling fluids. The primary components of BUTTPARK 100\07-45 include corrosion inhibitors, dispersants, and surfactants, which work together to form a protective film on metal surfaces, preventing corrosion and extending the lifespan of equipment and infrastructure in harsh operating environments. Additionally, it is designed to be environmentally friendly and biodegradable, making it suitable for use in sensitive ecosystems.

Upstream product

• 5398-69-6 2-iodo-3-nitrobenzoic acid 
• 85600-30-2 3-amino-2-iodo-benzoic acid 
• 535-80-8 3-chlorobenzoate 
• 861306-09-4 3-acetylamino-2-iodo-benzoic acid 
• 6388-47-2 2-amino-3-chlorobenzoic acid 

Downstream Products

• 1017540-70-3 3-chloro-2-iodobenzoyl chloride 
• 1613156-00-5 3-chloro-2-iodo-N-(4-methoxyphenyl)benzamide 
• 1613156-21-0 5-chloro-2-(4-methoxyphenyl)-3-(4-pentylphenyl)isoquinolin-1(2H)-one 
• 469912-65-0 3-chloro-2-iodobenzaldehyde 
• 1035262-61-3 ethyl 2-(3-chloro-2-iodophenyl)acetate 

Relevant articles and documents

Enantioselective Synthesis of N–C Axially Chiral Compounds by Cu-Catalyzed Atroposelective Aryl Amination

N?C axially chiral compounds have emerged recently as appealing motifs for drug design. However, the enantioselective synthesis of such molecules is still poorly developed and surprisingly no metal-catalyzed atroposelective N-arylations have been describe

Evolution of N-Heterocycle-Substituted Iodoarenes (NHIAs) to Efficient Organocatalysts in Iodine(I/III)-Mediated Oxidative Transformations

The reactivity of ortho-functionalized N-heterocycle-substituted iodoarenes (NHIAs) as organocatalysts in iodine(I/III)-mediated oxidations was systematically investigated in the α-tosyloxylation of ketones as the model reaction. During a systematic catalyst evolution, it was found that NH-triazoles and benzoxazoles have the most significant positive influence on the reactivity of the central iodine atom. A further catalyst improvement which focused on the substitution pattern of the arene revealed a remarkable ortho-effect. By introduction of an o-OMe group we were able to generate a novel NHIA with a so far unseen catalytic efficiency. This new catalyst is not only easy to synthesize but also enabled the α-tosyloxylation of carbonyl compounds at the lowest reported catalyst loading of only 1 mol%. Finally, the performance of this iodine(I) catalyst was successfully demonstrated in intramolecular oxidative couplings of biphenyls and oxidative rearrangements. (Figure presented.).

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.